SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001683168-18-000342
Filing Date
2018-02-07
Accepted
2018-02-07 16:55:57
Documents
1
Group Members
BRISTOL CAPITAL, LLCBRISTOL INVESTMENT FUND, LTD.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT bristol_13ga.htm SC 13G/A 68157
  Complete submission text file 0001683168-18-000342.txt   70144
Mailing Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602
Business Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602 (800) 304-9888
GT Biopharma, Inc. (Subject) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-32837 | Film No.: 18581749
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 89 NEXUS WAY CAMANA BAY, PO BOX 311063 GRAND CAYMAN E9 KY1-1205
Business Address 89 NEXUS WAY CAMANA BAY, PO BOX 311063 GRAND CAYMAN E9 KY1-1205 (310) 331-8485
BRISTOL INVESTMENT FUND LTD (Filed by) CIK: 0001174866 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A